Derek Miller - 06 Aug 2026 Form 4 Insider Report for AMGEN INC (AMGN)

Reporting relationship: SVP, Human Resources
Issuer ticker: AMGN
Reported as of: 06 Aug 2026
Net transaction value: -$1,565,898
SEC form: 4
Accepted by SEC: 07 Aug 2026, 18:47:09 UTC
Prior SEC filing: 11 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Derek Miller

Key filing fact

Derek Miller filed Form 4 for AMGEN INC (AMGN) on 07 Aug 2026.

Key facts

This page summarizes Derek Miller's Form 4 filing for AMGEN INC (AMGN).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 07 Aug 2026, 18:47.

Change

Previous filing in this sequence was filed on 11 May 2026.
Current net transaction value: -$1,565,898.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001917312 Primary reporting owner

Miller Derek

Relationship: SVP, Human Resources
Address: ONE AMGEN CENTER DRIVE, THOUSAND OAKS
Signature: /s/ Derek Miller
Signature date: 06 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMGN transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,069
Change %: +17%
Price: $162.60^*
Shares after: 14,531
Date: 06 Aug 2026
Ownership: Direct

AMGN transaction

Common Stock

Sale

Transaction value: $832,864
Shares: -2,069
Change %: -14%
Price: $402.54
Shares after: 12,462
Date: 06 Aug 2026
Ownership: Direct
Footnotes: F1, F2

AMGN transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,821
Change %: +15%
Price: $177.46^*
Shares after: 14,283
Date: 06 Aug 2026
Ownership: Direct

AMGN transaction

Common Stock

Sale

Transaction value: $733,033
Shares: -1,821
Change %: -13%
Price: $402.54
Shares after: 12,462
Date: 06 Aug 2026
Ownership: Direct
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMGN transaction Derivative

Nqso (Right to Buy)

Options Exercise

Transaction value
Shares: -2,069
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,069
Exercise price: $162.60

AMGN transaction Derivative

Nqso (Right to Buy)

Options Exercise

Transaction value
Shares: -1,821
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,821
Exercise price: $177.46

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options.

Footnote F2

The price reported is an average price of $402.5444 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer.

Footnote F3

These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.